nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—dilated cardiomyopathy	0.725	1	CbGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0236	0.177	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.0184	0.138	CbGpPWpGaD
Lisinopril—ACE—pulmonary artery—dilated cardiomyopathy	0.0129	0.213	CbGeAlD
Lisinopril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.0126	0.208	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0106	0.079	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00993	0.0743	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—dilated cardiomyopathy	0.00889	0.0665	CbGpPWpGaD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.00847	0.0634	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00821	0.0614	CbGpPWpGaD
Lisinopril—ACE2—cardiac ventricle—dilated cardiomyopathy	0.00821	0.136	CbGeAlD
Lisinopril—ABCB1—Spironolactone—dilated cardiomyopathy	0.00818	1	CbGbCtD
Lisinopril—ACE2—myocardium—dilated cardiomyopathy	0.00772	0.128	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.00763	0.0571	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.00564	0.0422	CbGpPWpGaD
Lisinopril—ACE2—heart—dilated cardiomyopathy	0.00539	0.0891	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00537	0.0402	CbGpPWpGaD
Lisinopril—ACE2—cardiac atrium—dilated cardiomyopathy	0.00461	0.0762	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00443	0.0332	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.00341	0.0255	CbGpPWpGaD
Lisinopril—ACE—cardiac ventricle—dilated cardiomyopathy	0.00268	0.0444	CbGeAlD
Lisinopril—ACE—myocardium—dilated cardiomyopathy	0.00252	0.0417	CbGeAlD
Lisinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.00252	0.0188	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.0024	0.0179	CbGpPWpGaD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.00234	0.0175	CbGpPWpGaD
Lisinopril—Breast pain—Spironolactone—dilated cardiomyopathy	0.00206	0.0317	CcSEcCtD
Lisinopril—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00184	0.0284	CcSEcCtD
Lisinopril—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00177	0.0272	CcSEcCtD
Lisinopril—ACE—heart—dilated cardiomyopathy	0.00176	0.0291	CbGeAlD
Lisinopril—ACE—cardiac atrium—dilated cardiomyopathy	0.00151	0.0249	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.00148	0.0111	CbGpPWpGaD
Lisinopril—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00142	0.0218	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.0013	0.00972	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.0013	0.00972	CbGpPWpGaD
Lisinopril—Ataxia—Spironolactone—dilated cardiomyopathy	0.00123	0.0189	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00118	0.0181	CcSEcCtD
Lisinopril—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00118	0.0181	CcSEcCtD
Lisinopril—Gastritis—Spironolactone—dilated cardiomyopathy	0.00116	0.0178	CcSEcCtD
Lisinopril—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00112	0.0172	CcSEcCtD
Lisinopril—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00111	0.0171	CcSEcCtD
Lisinopril—Fosinopril—ACE—dilated cardiomyopathy	0.0011	0.152	CrCbGaD
Lisinopril—Drug interaction—Furosemide—dilated cardiomyopathy	0.00106	0.0162	CcSEcCtD
Lisinopril—Gout—Furosemide—dilated cardiomyopathy	0.00105	0.0161	CcSEcCtD
Lisinopril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00104	0.016	CcSEcCtD
Lisinopril—Vasculitis—Furosemide—dilated cardiomyopathy	0.001	0.0154	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000998	0.0154	CcSEcCtD
Lisinopril—Renal failure—Spironolactone—dilated cardiomyopathy	0.00099	0.0152	CcSEcCtD
Lisinopril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00094	0.0145	CcSEcCtD
Lisinopril—Bladder pain—Furosemide—dilated cardiomyopathy	0.000885	0.0136	CcSEcCtD
Lisinopril—Spirapril—ACE—dilated cardiomyopathy	0.000883	0.123	CrCbGaD
Lisinopril—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000876	0.0135	CcSEcCtD
Lisinopril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000855	0.0131	CcSEcCtD
Lisinopril—Moexipril—ACE—dilated cardiomyopathy	0.000846	0.118	CrCbGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00082	0.00614	CbGpPWpGaD
Lisinopril—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000817	0.0126	CcSEcCtD
Lisinopril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00081	0.0125	CcSEcCtD
Lisinopril—Alopecia—Spironolactone—dilated cardiomyopathy	0.000799	0.0123	CcSEcCtD
Lisinopril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000787	0.0121	CcSEcCtD
Lisinopril—Quinapril—ACE—dilated cardiomyopathy	0.000787	0.11	CrCbGaD
Lisinopril—Cilazapril—ACE—dilated cardiomyopathy	0.000787	0.11	CrCbGaD
Lisinopril—Trandolapril—ACE—dilated cardiomyopathy	0.000762	0.106	CrCbGaD
Lisinopril—Ramipril—ACE—dilated cardiomyopathy	0.000762	0.106	CrCbGaD
Lisinopril—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000756	0.0116	CcSEcCtD
Lisinopril—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000734	0.0113	CcSEcCtD
Lisinopril—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00073	0.0112	CcSEcCtD
Lisinopril—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000714	0.011	CcSEcCtD
Lisinopril—Malaise—Spironolactone—dilated cardiomyopathy	0.00071	0.0109	CcSEcCtD
Lisinopril—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000704	0.0108	CcSEcCtD
Lisinopril—Benazepril—ACE—dilated cardiomyopathy	0.000684	0.0953	CrCbGaD
Lisinopril—Irritability—Furosemide—dilated cardiomyopathy	0.000678	0.0104	CcSEcCtD
Lisinopril—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000666	0.0102	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000662	0.00495	CbGpPWpGaD
Lisinopril—Discomfort—Spironolactone—dilated cardiomyopathy	0.000662	0.0102	CcSEcCtD
Lisinopril—Dehydration—Furosemide—dilated cardiomyopathy	0.000661	0.0102	CcSEcCtD
Lisinopril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000649	0.00999	CcSEcCtD
Lisinopril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000647	0.00996	CcSEcCtD
Lisinopril—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000642	0.00988	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00064	0.00985	CcSEcCtD
Lisinopril—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00064	0.00985	CcSEcCtD
Lisinopril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000629	0.00967	CcSEcCtD
Lisinopril—ABCB1—heart—dilated cardiomyopathy	0.00062	0.0103	CbGeAlD
Lisinopril—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000608	0.00936	CcSEcCtD
Lisinopril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000602	0.00927	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00058	0.00434	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00058	0.00434	CbGpPWpGaD
Lisinopril—Enalapril—ACE—dilated cardiomyopathy	0.000577	0.0804	CrCbGaD
Lisinopril—Somnolence—Spironolactone—dilated cardiomyopathy	0.000571	0.00878	CcSEcCtD
Lisinopril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000561	0.00863	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000554	0.00853	CcSEcCtD
Lisinopril—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000554	0.00853	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000543	0.00836	CcSEcCtD
Lisinopril—Renal failure—Furosemide—dilated cardiomyopathy	0.000538	0.00828	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000537	0.00401	CbGpPWpGaD
Lisinopril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000529	0.00814	CcSEcCtD
Lisinopril—Sweating—Furosemide—dilated cardiomyopathy	0.000525	0.00808	CcSEcCtD
Lisinopril—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000518	0.00797	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000511	0.00383	CbGpPWpGaD
Lisinopril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000511	0.00786	CcSEcCtD
Lisinopril—Urticaria—Spironolactone—dilated cardiomyopathy	0.00051	0.00785	CcSEcCtD
Lisinopril—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000508	0.00781	CcSEcCtD
Lisinopril—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000486	0.00747	CcSEcCtD
Lisinopril—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000482	0.00742	CcSEcCtD
Lisinopril—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000473	0.00728	CcSEcCtD
Lisinopril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000465	0.00715	CcSEcCtD
Lisinopril—Tinnitus—Furosemide—dilated cardiomyopathy	0.000458	0.00705	CcSEcCtD
Lisinopril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000454	0.00699	CcSEcCtD
Lisinopril—Angiopathy—Furosemide—dilated cardiomyopathy	0.000446	0.00686	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000441	0.0033	CbGpPWpGaD
Lisinopril—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000439	0.00676	CcSEcCtD
Lisinopril—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000439	0.00676	CcSEcCtD
Lisinopril—Erythema—Furosemide—dilated cardiomyopathy	0.000428	0.00659	CcSEcCtD
Lisinopril—Malnutrition—Furosemide—dilated cardiomyopathy	0.000428	0.00659	CcSEcCtD
Lisinopril—Dizziness—Spironolactone—dilated cardiomyopathy	0.000425	0.00653	CcSEcCtD
Lisinopril—Flatulence—Furosemide—dilated cardiomyopathy	0.000422	0.00649	CcSEcCtD
Lisinopril—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000419	0.00645	CcSEcCtD
Lisinopril—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000412	0.00633	CcSEcCtD
Lisinopril—Vomiting—Spironolactone—dilated cardiomyopathy	0.000408	0.00628	CcSEcCtD
Lisinopril—Rash—Spironolactone—dilated cardiomyopathy	0.000405	0.00623	CcSEcCtD
Lisinopril—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000405	0.00622	CcSEcCtD
Lisinopril—Vision blurred—Furosemide—dilated cardiomyopathy	0.000403	0.00621	CcSEcCtD
Lisinopril—Headache—Spironolactone—dilated cardiomyopathy	0.000402	0.00619	CcSEcCtD
Lisinopril—Anaemia—Furosemide—dilated cardiomyopathy	0.000396	0.00609	CcSEcCtD
Lisinopril—Vertigo—Furosemide—dilated cardiomyopathy	0.000385	0.00592	CcSEcCtD
Lisinopril—Leukopenia—Furosemide—dilated cardiomyopathy	0.000383	0.0059	CcSEcCtD
Lisinopril—Nausea—Spironolactone—dilated cardiomyopathy	0.000381	0.00587	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000362	0.00557	CcSEcCtD
Lisinopril—Dry mouth—Furosemide—dilated cardiomyopathy	0.000356	0.00548	CcSEcCtD
Lisinopril—Confusional state—Furosemide—dilated cardiomyopathy	0.000352	0.00542	CcSEcCtD
Lisinopril—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000349	0.00538	CcSEcCtD
Lisinopril—Shock—Furosemide—dilated cardiomyopathy	0.000344	0.00529	CcSEcCtD
Lisinopril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000342	0.00526	CcSEcCtD
Lisinopril—Skin disorder—Furosemide—dilated cardiomyopathy	0.000339	0.00522	CcSEcCtD
Lisinopril—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000338	0.0052	CcSEcCtD
Lisinopril—Anorexia—Furosemide—dilated cardiomyopathy	0.000333	0.00512	CcSEcCtD
Lisinopril—Hypotension—Furosemide—dilated cardiomyopathy	0.000326	0.00502	CcSEcCtD
Lisinopril—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000314	0.00483	CcSEcCtD
Lisinopril—Somnolence—Furosemide—dilated cardiomyopathy	0.000311	0.00478	CcSEcCtD
Lisinopril—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000304	0.00467	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000302	0.00464	CcSEcCtD
Lisinopril—Fatigue—Furosemide—dilated cardiomyopathy	0.000301	0.00463	CcSEcCtD
Lisinopril—Pain—Furosemide—dilated cardiomyopathy	0.000299	0.0046	CcSEcCtD
Lisinopril—Constipation—Furosemide—dilated cardiomyopathy	0.000299	0.0046	CcSEcCtD
Lisinopril—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000288	0.00443	CcSEcCtD
Lisinopril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000286	0.0044	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00028	0.0021	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—AGT—dilated cardiomyopathy	0.00028	0.00209	CbGpPWpGaD
Lisinopril—Urticaria—Furosemide—dilated cardiomyopathy	0.000278	0.00427	CcSEcCtD
Lisinopril—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000276	0.00425	CcSEcCtD
Lisinopril—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000276	0.00425	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000273	0.00204	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000273	0.00204	CbGpPWpGaD
Lisinopril—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000257	0.00396	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000253	0.0019	CbGpPWpGaD
Lisinopril—Asthenia—Furosemide—dilated cardiomyopathy	0.000251	0.00386	CcSEcCtD
Lisinopril—Pruritus—Furosemide—dilated cardiomyopathy	0.000247	0.0038	CcSEcCtD
Lisinopril—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000239	0.00368	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000232	0.00174	CbGpPWpGaD
Lisinopril—Dizziness—Furosemide—dilated cardiomyopathy	0.000231	0.00355	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000228	0.00171	CbGpPWpGaD
Lisinopril—Vomiting—Furosemide—dilated cardiomyopathy	0.000222	0.00342	CcSEcCtD
Lisinopril—Rash—Furosemide—dilated cardiomyopathy	0.00022	0.00339	CcSEcCtD
Lisinopril—Dermatitis—Furosemide—dilated cardiomyopathy	0.00022	0.00339	CcSEcCtD
Lisinopril—Headache—Furosemide—dilated cardiomyopathy	0.000219	0.00337	CcSEcCtD
Lisinopril—Nausea—Furosemide—dilated cardiomyopathy	0.000208	0.00319	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000195	0.00146	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000164	0.00122	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000152	0.00114	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000147	0.0011	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000125	0.000935	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.48e-05	0.000709	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.22e-05	0.00069	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.22e-05	0.00069	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.57e-05	0.000641	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7.51e-05	0.000562	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	7.24e-05	0.000542	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.1e-05	0.000531	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	6.23e-05	0.000466	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	6.23e-05	0.000466	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.86e-05	0.000438	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.53e-05	0.000414	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	5.3e-05	0.000396	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.71e-05	0.000352	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.23e-05	0.000242	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.07e-05	0.00023	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.87e-05	0.00014	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.26e-05	9.44e-05	CbGpPWpGaD
